市場調查報告書
商品編碼
1466620
細胞分離/細胞分離市場:按產品類型、細胞來源、技術、應用、最終用戶 - 2024-2030 年全球預測Cell Isolation/Cell Separation Market by Product (Consumables, Instruments), Cell Type (Animal Cells, Human Cells), Cell Source, Technique, Application, End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
細胞分離/細胞分離市場規模預估2023年為113.2億美元,2024年達129.3億美元,2030年達到291.2億美元,預估複合年成長率為14.44%。
細胞分離,也稱為細胞分離,是生命科學和醫學研究中的關鍵過程,它允許從異質混合物中提取和分離特定的細胞類型,以便進一步分析、研究或治療用途。這個過程對於多種應用至關重要,包括癌症研究、幹細胞研究、免疫學和組織再生。這種應用的擴展主要是由於技術進步促進了細胞治療的更高純度和產量、需要個人化醫療的慢性疾病的日益流行以及對細胞研究的投資增加。然而,這個過程在技術上困難、昂貴、耗時,並且存在細胞損傷和喪失的潛在風險。為了解決這些問題,目前的重點是開發結合自動化和微流體技術的更有效率、更具成本效益和良性的分離技術。隨著新的治療應用的開發、與人工智慧的整合以提高效率以及為細胞功能和疾病機制提供無與倫比的洞察力的單細胞技術的出現等新興機遇,細胞分離正在經歷顯著的成長。
主要市場統計 | |
---|---|
基準年[2023] | 113.2億美元 |
預測年份 [2024] | 129.3億美元 |
預測年份 [2030] | 291.2億美元 |
複合年成長率(%) | 14.44% |
使用耗材確保產品結果的一致性和可靠性
耗材對於細胞分離過程至關重要,提供有效分離所需的試劑和材料。此部分進一步分為試劑、珠子和消耗品。試劑包括對細胞裂解和分離很重要的酵素和緩衝液。珠子(磁珠)提供了一種利用磁場的細胞分選方法。消耗品包括過濾器和板子等各種產品。細胞分離儀器包括用於分離和收集特定細胞類型的儀器。此領域分為離心機、流式細胞儀、磁激活細胞分選儀(MACS)和過濾系統。這些設備之一的選擇取決於細胞分離的方法和所需的結果。雖然離心機通常用於滿足基本的細胞分離需求,但流式細胞儀和 MACS 可以更精確地對特定細胞類型進行分選。過濾系統是批量分離的首選。
最終用戶:研究機構快速普及細胞分離程序
生物技術和生物製藥公司佔據了細胞分離市場的主要部分。這些公司主要專注於開發療法、疫苗和研究新藥。這些公司優先考慮自動化、高通量系統,這些系統可以處理大量樣品,而不會影響細胞分離的品質。醫院和診斷實驗室將細胞分離用於多種目的,包括診斷測定、臨床試驗和個人化醫療。這部分強調準確性、可靠性和速度,以幫助做出診斷和治療決策。這些用戶需要一個易於使用且強大的系統,能夠快速提供結果。首選與現有工作流程無縫整合且需要最少操作員培訓的設備。研究機構和機構處於細胞基礎和應用研究的前沿。他們的需求集中在多功能性、敏感性以及分離稀有細胞群以用於疾病或再生醫學等研究的能力。這些研究機構喜歡提供廣泛功能的模組化系統,包括分離不同細胞類型和適應不同研究需求的能力。
區域洞察
在美洲,在醫療保健和強大的生物新興企業生態系統的大量投資的推動下,生物技術和製藥行業專注於利用先進的研究方法和細胞分離技術。區域公司在該地區佔據主導地位,受益於完善的基礎設施以及對創新和技術進步的高度重視。亞太地區細胞分離技術的採用正在迅速增加,這主要是由於政府對生物技術研究的投資增加、生物技術公司的快速發展以及對個人化醫療的日益關注。然而,該地區在生產能力和技術成熟度方面面臨挑戰,企業努力與西方國家的技術力相符。 EMEA(歐洲、中東和非洲)地區的情況好壞參半,因為歐洲在政府的大力支持下處於研發活動的前沿。由於醫療保健支出和意識的增加,中東和非洲逐漸成為潛在市場。歐洲、中東和非洲地區的公司對於推動創新至關重要,但它們面臨來自全球巨頭和亞太地區新興企業的激烈競爭。
FPNV定位矩陣
FPNV定位矩陣對於評估細胞分離/細胞分離市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對細胞隔離/細胞分離市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1. 細胞分離/細胞分離市場的市場規模與預測是多少?
2.在細胞分離/細胞分離市場的預測期內,有哪些產品、細分市場、應用和領域需要考慮投資?
3.細胞分離/細胞分離市場的技術趨勢和法規結構是什麼?
4.細胞分離/細胞分離市場主要廠商的市場佔有率是多少?
5. 進入細胞分離/細胞分離市場的適當型態和策略手段是什麼?
生物過程
[197 Pages Report] The Cell Isolation/Cell Separation Market size was estimated at USD 11.32 billion in 2023 and expected to reach USD 12.93 billion in 2024, at a CAGR 14.44% to reach USD 29.12 billion by 2030.
Cell isolation, also known as cell separation, is a pivotal process in life sciences and medical research, enabling the extraction and separation of specific cell types from a heterogeneous mixture for further analysis, research, or therapeutic use. This process is crucial in various applications including cancer research, stem cell research, immunology, and tissue regeneration. The expansion of its use is primarily driven by technological advancements facilitating higher purity and yield in cell therapy, increasing the prevalence of chronic diseases necessitating personalized medicine, and growing investments in cell-based research. However, the process can be technically challenging, expensive, and time-consuming, with potential risks of cell damage or loss. Addressing these issues, ongoing efforts focus on developing more efficient, cost-effective, and gentle separation techniques, incorporating automation and microfluidic technologies. Cell isolation is poised for significant growth, with opportunities emerging in the development of novel therapeutic applications, integration with artificial intelligence for improved efficiency, and the advent of single-cell technologies offering unparalleled insights into cell function and disease mechanisms.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 11.32 billion |
Estimated Year [2024] | USD 12.93 billion |
Forecast Year [2030] | USD 29.12 billion |
CAGR (%) | 14.44% |
Product: Use of consumables to ensure consistency and reliability in results
Consumables are vital to the cell isolation process, offering the necessary reagents and materials for effective separation. This segment is further divided into reagents, beads, and disposables. Reagents include enzymes and buffer solutions critical for cell lysis and separation. Beads, or magnetic beads, offer a method for cell sorting using magnetic fields. Disposables cover a range of products like filters and plates. Instruments in cell isolation encompass devices used in the separation and collection of specific cell types. This segment can be divided into centrifuges, flow cytometers, magnetic-activated cell sorters (MACS), and filtration systems. The preference between these instruments is dictated by the cell isolation method and the desired outcome. Centrifuges are commonly used for basic cell separation needs, whereas flow cytometers and MACS offer higher precision for sorting specific cell types. Filtration systems are preferred for large-volume separations.
End-User: Exponential adoption of cell isolation procedures by research institutes
Biotechnology and biopharmaceutical companies represent a major segment of the cell isolation market. These entities primarily focus on the development of therapeutics, vaccines, and research into novel drug modalities. These companies prioritize automated, high-throughput systems that can handle large volumes without compromising the quality of cell separation. Hospitals and diagnostic laboratories utilize cell isolation for various purposes, including diagnostic assays, clinical trials, and personalized medicine. This segment focuses on accuracy, reliability, and speed to aid in diagnosis and treatment decision-making. These users need easy-to-use, robust systems that can deliver rapid results. Equipment that integrates seamlessly with existing workflows and requires minimal operator training is preferred. Research laboratories and institutes are at the forefront of basic and applied research involving cell-based studies. Their needs center around versatility, sensitivity, and the ability to isolate rare cell populations for research into diseases, regenerative medicine, and more. These entities prefer modular systems that offer a wide range of capabilities, including the isolation of various cell types and the ability to adapt to different research needs.
Regional Insights
In the Americas, there is a strong emphasis on advanced research methodologies and the utilization of cell separation technologies in the biotechnology and pharmaceutical sectors, propelled by substantial investments in healthcare and a robust biotech startup ecosystem. Regional companies are dominating the region, benefitting from a well-established infrastructure and a significant focus on innovation and technological advancement. The APAC region is witnessing rapid growth in the adoption of cell isolation technologies, primarily due to increasing government investment in biotechnology research, burgeoning biotech enterprises, and a rising focus on personalized medicine. However, the region faces challenges in terms of production capabilities and technical sophistication, with companies striving to match the technological prowess seen in Western counterparts. The EMEA region presents a mixed scenario, with Europe at the forefront in terms of research and development activities driven by strong governmental support. The Middle East and Africa are slowly emerging as potential markets, owing to increasing healthcare expenditure and awareness. Companies in EMEA are pivotal in driving innovation, although they face stiff competition from global giants and emerging players in APAC.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Cell Isolation/Cell Separation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Isolation/Cell Separation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Cell Isolation/Cell Separation Market, highlighting leading vendors and their innovative profiles. These include Akadeum Life Sciences, Alfa Laval AB, Beckman Coulter, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioLegend, Inc. by PerkinElmer Inc., Capricorn Scientific, CD Bioparticles, Corning Incorporated, Cytiva by Global Life Sciences Solutions USA LLC, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc., GenScript Biotech Corporation, IDEX Health & Science LLC, Invent Biotechnologies, Inc., LeanGene, Merck KGA, MiCareo Inc., Miltenyi Biotec B.V. & Co. KG, NVIGEN, Inc., pluriSelect Life Science UG & Co. KG, Promega Corporation, PromoCell GmbH, Proteintech Group, Inc., Sartorius AG, STEMCELL Technologies Inc., Takara Bio Inc., Terumo BCT, Inc., and Thermo Fisher Scientific, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Cell Isolation/Cell Separation Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Isolation/Cell Separation Market?
3. What are the technology trends and regulatory frameworks in the Cell Isolation/Cell Separation Market?
4. What is the market share of the leading vendors in the Cell Isolation/Cell Separation Market?
5. Which modes and strategic moves are suitable for entering the Cell Isolation/Cell Separation Market?
bioprocessing